E-LIB Suche - Ergebnisse für: Thudium Mueller, Karen

1

Next-Generation Sequencing of Minimal Residual Disease for ..:

Pulsipher, Michael A. ; Han, Xia ; Maude, Shannon L....
Blood Cancer Discovery. 3 (2021) 1 - p. 66-81 , 2021

Link: https://doi.org/10.1158/..

2

Tisagenlecleucel immunogenicity in relapsed/refractory acut..:

Thudium Mueller, Karen ; Grupp, Stephan A. ; Maude, Shannon L....
Blood Advances. 5 (2021) 23 - p. 4980-4991 , 2021

Link: https://doi.org/10.1182/..

3

Monitoring of tisagenlecleucel transgene DNA using a quanti..:

Davis, Lisa ; Riccitelli, Nathan ; Valencia, Nancy...
Molecular Therapy - Methods & Clinical Development. 20 (2021) - p. 535-541 , 2021

Link: https://doi.org/10.1016/..

4

Current and Next Steps Toward Prediction of Human Dose for ..:

Aksenov, Sergey ; Roberts, John C. ; Mugundu, Ganesh...
Clinical Pharmacology & Therapeutics. 110 (2021) 5 - p. 1176-1179 , 2021

Link: https://doi.org/10.1002/..

5

The role of clinical pharmacology across novel treatment mo..:

Mueller, Karen Thudium ; Li, Chi‐Chung ; Phipps, Alex
Clinical Pharmacology & Therapeutics. 108 (2020) 3 - p. 413-415 , 2020

Link: https://doi.org/10.1002/..

6

Tisagenlecleucel cellular kinetics, dose, and immunogenicit..:

Awasthi, Rakesh ; Pacaud, Lida ; Waldron, Edward...
Blood Advances. 4 (2020) 3 - p. 560-572 , 2020

Link: https://doi.org/10.1182/..

7

Tisagenlecleucel Model‐Based Cellular Kinetic Analysis of C..:

Stein, Andrew M. ; Grupp, Stephan A. ; Levine, John E....
CPT: Pharmacometrics & Systems Pharmacology. 8 (2019) 5 - p. 285-295 , 2019

Link: https://doi.org/10.1002/..

8

Tisagenlecleucel for the Treatment of Pediatric and Young A..:

Grupp, Stephan A. ; Maude, Shannon L. ; Rives, Susana...
Biology of Blood and Marrow Transplantation. 25 (2019) 3 - p. S126-S127 , 2019

Link: https://doi.org/10.1016/..

9

CTL019 Clinical Pharmacology and Biopharmaceutics in Pediat..:

Mueller, Karen Thudium ; Waldron, Edward ; Grupp, Stephan A....
Clinical Lymphoma Myeloma and Leukemia. 17 (2017) - p. S261-S262 , 2017

Link: https://doi.org/10.1016/..

10

Global Registration Trial of Efficacy and Safety of CTL019 ..:

Buechner, Jochen ; Grupp, Stephan A. ; Maude, Shannon L....
Clinical Lymphoma Myeloma and Leukemia. 17 (2017) - p. S263-S264 , 2017

Link: https://doi.org/10.1016/..

11

Monitoring of tisagenlecleucel transgene DNA using a quanti..:

Lisa Davis ; Nathan Riccitelli ; Nancy Valencia...
http://www.sciencedirect.com/science/article/pii/S2329050120302503. , 2021

Link: https://doi.org/10.1016/..

12

Tisagenlecleucel Model‐Based Cellular Kinetic Analysis of C..:

Andrew M. Stein ; Stephan A. Grupp ; John E. Levine...
https://doi.org/10.1002/psp4.12388. , 2019

Link: https://doi.org/10.1002/..

13

Immunogenicity of Antibody Drug Conjugates: Bioanalytical M..:

Hock, M. Benjamin ; Thudium, Karen E. ; Carrasco-Triguero, Montserrat.
The AAPS Journal. 17 (2014) 1 - p. 35-43 , 2014

Link: https://doi.org/10.1208/..

14

Synergism between clofarabine and decitabine through p53R2:..:

Thudium, Karen E. ; Ghoshal, Sampa ; Fetterly, Gerald J....
Leukemia Research. 36 (2012) 11 - p. 1410-1416 , 2012

Link: https://doi.org/10.1016/..

15

Bioavailability of everolimus administered as a single 5 mg..:

Cheung, Wing ; Thudium, Karen ; Gallo, Jorge...
Clinical Pharmacology: Advances and Applications. , 2015

Link: https://doi.org/10.2147/..